Engineered M13 phage-based biosensor offers rapid, label-free detection of SARS-CoV-2 spike protein, demonstrating femtogram-level sensitivity in tests.
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...
Nandkumar M. Kamat In December 2019, a cluster of unusual pneumonia cases surfaced in Wuhan, China. Within weeks, the world ...
COVID-19 vaccination during the 2024-2025 respiratory virus season was associated with protection against hospitalization.
A review published in Infection highlights viral mimic systems that safely replicate key features of pathogens like SARS-CoV-2. These technologies allow vaccine testing in lower-level biosafety ...
Emergency Care Reduction: The study of the 2024–2025 vaccine showed a 29.3% effectiveness (95% confidence interval [CI], 19.1 to 39.2) against Covid-19–related ED visits, preventing approximately 18.3 ...
Stanford Medicine researchers have developed an experimental nasal spray vaccine that protected mice against SARS‑CoV‑2, influenza, and Streptococcus pneumoniae (a cause of bacterial pneumonia) with a ...
Objective India had an estimated three to five million excess deaths from causes attributable to SARS-CoV-2 during 2020–2021, ...
In northern Italy, at least eight species of bat (Chiroptera) use the areas around pig farms. The lack of physical barriers ...
The University of Chicago will award honorary degrees to three distinguished scholars on June 6 during its Convocation ...
With the CHMP affirmation, Moderna is on course to get EU approval for its fourth vaccine product and break new ground in ...
Approximately one in seven adults in the United States has kidney disease, where the organs responsible for filtering waste ...